Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021

Clinical trial NCT07302607 · RECRUITING

Trial details

NCT number: NCT07302607
Sponsor: University Hospital, Strasbourg, France
Status: RECRUITING
Study type: OBSERVATIONAL

Stage III Melanoma

Start date: 2024-12-11
Primary completion: 2026-01-01
Enrollment: 221

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.